Guidelines for Clinical Evaluation, Development, and Regulation of Lipid-Acting Anti-Atherosclerosis Agents

Carlos A. Dujovne

Б 133

Детайли

Издателство

Exerpta Medica

Година на издаване

1998

Страници

75 p.

Класификационен индекс

УДК	Значение
616.13-004.6	Артериосклероза

Тематична група

Суплемент

Допълнителна информация

ISBN: 0002-9149
Отрасъл: Патология. Клин. медицина. Диагностика *616
Системен №: 4844
Тематични рубрики: Кардиология
Предметни рубрики: Кардиология - учебници и ръководства, Артериосклероза

Действия

APA Chicago / Turabian (16th edition) Harvard MLA (7th edition) Vancouver

Dujovne, C. Guidelines for Clinical Evaluation, Development, and Regulation of Lipid-Acting Anti-Atherosclerosis Agents. Exerpta Medica, 1998 75 p. 0002-9149.

Dujovne, C. (1998) Guidelines for Clinical Evaluation, Development, and Regulation of Lipid-Acting Anti-Atherosclerosis Agents, Exerpta Medica 75 p. 0002-9149.

Dujovne, C. (1998). Guidelines for Clinical Evaluation, Development, and Regulation of Lipid-Acting Anti-Atherosclerosis Agents. Exerpta Medica, 75 p.

Dujovne C. Guidelines for Clinical Evaluation, Development, and Regulation of Lipid-Acting Anti-Atherosclerosis Agents. Exerpta Medica; 1998. p. 75 p. ISBN: 0002-9149.